This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 12 pp 11623—11635
Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis
Figure 5. Interactions among hsa_circ_0101145, miR-548c-3p, and LAMC2. (A) RT-qPCR analyses revealed that miR-548c-3p was the only miRNA that was abundantly pulled down by the hsa_circ_0101145 probe in HepG2 cells. Data are presented as means ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 vs oligo. (B) RT-qPCR shows the expression of miR-548c-3p in HCC tissues (60) and adjacent normal tissues (60). Data are presented as the mean ± SD. ***P < 0.001 vs. Normal. (C) Prediction of binding sites of miR-548c-3p in hsa_circ_0101145. The mutant version of hsa_circ_0101145 is presented. (D) Relative luciferase activity determined at 48 h after transfection of 293T cells with miR-548c-3p mimic/NC or hsa_circ_0101145 wild-type/Mut. Data are presented as means ± SD. ***P < 0.001. (E) Prediction of binding sites of miR-548c-3p in the 3'UTR of LAMC2. The mutant version of 3'UTR-LAMC2 is shown. (F) Relative luciferase activity determined at 48 h after transfection of 293T cells with miR-548c-3p mimic/NC or 3'UTR-LAMC2 wild-type/Mut. Data are presented as means ± SD. ***P < 0.001.